1. Home
  2. MREO vs LVRO Comparison

MREO vs LVRO Comparison

Compare MREO & LVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • LVRO
  • Stock Information
  • Founded
  • MREO 2015
  • LVRO 2017
  • Country
  • MREO United Kingdom
  • LVRO Brazil
  • Employees
  • MREO N/A
  • LVRO N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • LVRO Blank Checks
  • Sector
  • MREO Health Care
  • LVRO Finance
  • Exchange
  • MREO Nasdaq
  • LVRO Nasdaq
  • Market Cap
  • MREO 369.2M
  • LVRO 387.1M
  • IPO Year
  • MREO N/A
  • LVRO N/A
  • Fundamental
  • Price
  • MREO $2.26
  • LVRO $3.03
  • Analyst Decision
  • MREO Strong Buy
  • LVRO Strong Buy
  • Analyst Count
  • MREO 7
  • LVRO 3
  • Target Price
  • MREO $7.71
  • LVRO $5.83
  • AVG Volume (30 Days)
  • MREO 1.2M
  • LVRO 10.4K
  • Earning Date
  • MREO 03-26-2025
  • LVRO 04-04-2025
  • Dividend Yield
  • MREO N/A
  • LVRO N/A
  • EPS Growth
  • MREO N/A
  • LVRO N/A
  • EPS
  • MREO N/A
  • LVRO N/A
  • Revenue
  • MREO N/A
  • LVRO $1,667,345,189.00
  • Revenue This Year
  • MREO N/A
  • LVRO N/A
  • Revenue Next Year
  • MREO $69.09
  • LVRO $13.35
  • P/E Ratio
  • MREO N/A
  • LVRO N/A
  • Revenue Growth
  • MREO N/A
  • LVRO N/A
  • 52 Week Low
  • MREO $2.16
  • LVRO $3.00
  • 52 Week High
  • MREO $5.02
  • LVRO $7.00
  • Technical
  • Relative Strength Index (RSI)
  • MREO 33.19
  • LVRO 28.91
  • Support Level
  • MREO $2.23
  • LVRO $3.00
  • Resistance Level
  • MREO $2.73
  • LVRO $3.87
  • Average True Range (ATR)
  • MREO 0.14
  • LVRO 0.36
  • MACD
  • MREO -0.01
  • LVRO -0.09
  • Stochastic Oscillator
  • MREO 7.89
  • LVRO 2.13

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

Share on Social Networks: